Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated network

11 Oct 2022

Abstract excerpt

PURPOSE: Coronavirus disease 2019 (COVID-19) continues to threaten public health globally. Severe acute respiratory coronavirus type 2 (SARS-CoV-2) infection-dependent alterations in the host cell signaling network may unveil potential target proteins and pathways for therapeutic strategies. In this study, we aim to define early severity biomarkers and monitor altered pathways in the course of SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36217943
DOI: 10.1002/prca.202200070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkPMID 36217943Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read ↗

Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity AssessmentSemantic proximity Read ↗

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes.Semantic proximity Read ↗

Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathwaysSemantic proximity Read ↗

Proteomics Analysis of Serum from COVID-19 PatientsSemantic proximity Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID‐19 progressionSemantic proximity Read ↗

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read ↗

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptomsSemantic proximity Read ↗

The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype.Semantic proximity Read ↗

Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 DiseaseSemantic proximity Read ↗

Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS InvestigationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.